Effects of methylphenidate in ADHD adults on target evaluation processing reflected by event-related potentials

Neuroscience Letters

Volumn 424, Issue 3, 2007, Pages 149-154

  Ohlmeier, Martin D ^a   Prox, Vanessa ^a   Zhang, Yuanyuan ^a   Zedler, Markus ^a   Ziegenbein, Marc ^a   Emrich, Hinderk M ^a   Dietrich, Detlef E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ADHD; Attentional processing; Event related potentials; Go NoGo experiment; N1; N2; P3

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; ELECTRODE; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN TARGETING; REACTION TIME; SLOW BRAIN WAVE; STATISTICAL SIGNIFICANCE; WAVEFORM;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION;

EID: 34548629413     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.055     Document Type: Article

References (50)

1. Afifi A.K. Basal ganglia: functional anatomy and physiology, Part 2. J. Child Neurol. 9 (1994) 352-361
2. American Psychiatric Association. DSM-IV Diagnostic Criteria of the Attention-deficit/Hyperactivity Disorder (1994), American Psychiatric Association
3. Arnsten A.F., Steere J.C., and Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53 (1996) 448-455
4. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121 (1997) 65-94
5. Barkley R.A. Attention-deficit hyperactivity disorder. Sci. Am. 279 (1998) 66-71
6. Barkley R.A., Fischer M., Smallish L., and Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111 (2003) 97-109
7. Biederman J., Faraone S.V., Spencer T., Wilens T., Norman D., Lapey K.A., Mick E., Lehman B.K., and Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 150 (1993) 1792-1798
8. Bouffard R., Hechtman L., Minde K., and Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can. J. Psychiatry 48 (2003) 546-554
9. Bradley C. The behavior of children receiving Benzedrine. Am. J. Psychiatry 94 (1937) 577-585
10. Brodeur D.A., and Pond M. The development of selective attention in children with attention deficit hyperactivity disorder. J. Abnorm. Child Psychol. 29 (2001) 229-239
11. Bush G., Frazier J.A., Rauch S.L., Seidman L.J., Whalen P.J., Jenike M.A., Rosen B.R., and Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol. Psychiatry 45 (1999) 1542-1552
12. Carter C.S., Krener P., Chaderjian M., Northcutt C., and Wolfe V. Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biol. Psychiatry 37 (1995) 789-797
13. Clark C.R., Geffen G.M., and Geffen L.B. Catecholamines and attention. I. Animal and clinical studies. Neurosci. Biobehav. Rev. 11 (1987) 341-352
14. C.K. Conners, D. Erhardt, E. Sparrow, Conners' Adult ADHD Rating Scales (CAARS), 1999.
15. Cooper N.J., Keage H., Hermens D., Williams L.M., Debrota D., Clark C.R., and Gordon E. The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology. J. Integr. Neurosci. 4 (2005) 123-144
16. Dietrich D.E., Hauser U., Peters M., Zhang Y., Wiesmann M., Hasselmann M., Rudolf S., Jungling O., Kirchner H., Munte T.F., Arolt V., Emrich H.M., Johannes S., and Rothermundt M. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression. Neurosci. Lett. 354 (2004) 69-73
17. Dietrich D.E., Zhang Y., Bode L., Munte T.F., Hauser U., Schmorl P., Richter-Witte C., Godecke-Koch T., Feutl S., Schramm J., Ludwig H., Johannes S., and Emrich H.M. Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol. Psychiatry 10 (2005) 519-520
18. Dresel S., Krause J., Krause K.H., LaFougere C., Brinkbaumer K., Kung H.F., Hahn K., and Tatsch K. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur. J. Nucl. Med. 27 (2000) 1518-1524
19. Fallu A., Richard C., Prinzo R., and Binder C. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Curr. Med. Res. Opin. 22 (2006) 2557-2566
20. Gross J., Blocher D., Trott G.E., and Rosler M. Assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 70 (1999) 20-25
21. Hermens D.F., Williams L.M., Clarke S., Kohn M., Cooper N., and Gordon E. Responses to methylphenidate in adolescent AD/HD: evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int. J. Psychophysiol. 58 (2005) 21-33
22. Hill D. Amphetamine in psychopathic states. Br. J. Addict. 44 (1947) 50-54
23. Hillyard S.A., Squires K.C., Bauer J.W., and Lindsay P.H. Evoked potential correlates of auditory signal detection. Science 172 (1971) 1357-1360
24. Jennings J.R., and Wood C.C. Letter: the epsilon-adjustment procedure for repeated-measures analyses of variance. Psychophysiology 13 (1976) 277-278
25. Jodo E., and Kayama Y. Relation of a negative ERP component to response inhibition in a Go/No-go task. Electroencephalogr. Clin. Neurophysiol. 82 (1992) 477-482
26. Jonkman L.M. The development of preparation, conflict monitoring and inhibition from early childhood to young adulthood: a Go/Nogo ERP study. Brain Res. 1097 (2006) 181-193
27. Kemner C., Verbaten M.N., Koelega H.S., Camfferman G., and van Engeland H. Are abnormal event-related potentials specific to children with ADHD? A comparison with two clinical groups. Percept. Mot. Skills 87 (1998) 1083-1090
28. Klem G.H., Luders H.O., Jasper H.H., and Elger C. The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 52 (1999) 3-6
29. Klorman R. Cognitive event-related potentials in attention deficit disorder. J. Learn. Disabil. 24 (1991) 130-140
30. Krause K.H., Dresel S.H., Krause J., Kung H.F., and Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285 (2000) 107-110
31. Krause K.H., Krause J., and Trott G.E. Hyperkinetic syndrome (attention-deficit/hyperactivity disorder) in adulthood. Nervenarzt 69 (1998) 543-556
32. Lopez J., Lopez V., Rojas D., Carrasco X., Rothhammer P., Garcia R., Rothhammer F., and Aboitiz F. Effect of psychostimulants on distinct attentional parameters in attentional deficit/hyperactivity disorder. Biol. Res. 37 (2004) 461-468
33. Masellis M., Basile V.S., Muglia P., Ozdemir V., Macciardi F.M., and Kennedy J.L. Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder. Behav. Brain Res. 130 (2002) 85-90
34. Mehta M.A., Calloway P., and Sahakian B.J. Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J. Psychopharmacol. 14 (2000) 299-302
35. Miller J., and Hackley S.A. Electrophysiological evidence for temporal overlap among contingent mental processes. J. Exp. Psychol. Gen. 121 (1992) 195-209
36. Munoz D.P., Armstrong I.T., Hampton K.A., and Moore K.D. Altered control of visual fixation and saccadic eye movements in attention-deficit hyperactivity disorder. J. Neurophysiol. 90 (2003) 503-514
37. Münte T.F. Event-related brain potentials in the study of human cognition and neuropsychology. In: Boller F., Grafman J., and Rizzolatti G. (Eds). Handbook of Neuropsychology (2000), Elsevier 139-235
38. Munte T.F., Munte E., Heinze H.J., and Scholz M. Event related brain potentials and signal detection: decision confidence and signal probability. EEG. EMG. Z. Elektroenzephalogr. Elektromyogr. Verwandte. Geb. 20 (1989) 1-9
39. Prox V., Dietrich D.E., Zhang Y., Emrich H.M., and Ohlmeier M.D. Attentional processing in adults with ADHD as reflected by event-related potentials. Neurosci. Lett. 419 (2007) 236-241
40. Seifert J., Scheuerpflug P., Zillessen K.E., Fallgatter A., and Warnke A. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J. Neural Transm. 110 (2003) 821-829
41. Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 24 (2000) 7-12
42. Shelley-Tremblay J.F., and Rosen L.A. Attention deficit hyperactivity disorder: an evolutionary perspective. J. Genet. Psychol. 157 (1996) 443-453
43. Smalley S.L., Bailey J.N., Palmer C.G., Cantwell D.P., McGough J.J., Del'Homme M.A., Asarnow J.R., Woodward J.A., Ramsey C., and Nelson S.F. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol. Psychiatry 3 (1998) 427-430
44. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 130 (2002) 65-71
45. Sunohara G.A., Malone M.A., Rovet J., Humphries T., Roberts W., and Taylor M.J. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology 21 (1999) 218-228
46. Tucha O., Mecklinger L., Laufkotter R., Klein H.E., Walitza S., and Lange K.W. Methylphenidate-induced improvements of various measures of attention in adults with Attention Deficit Hyperactivity Disorder. J. Neural Transm. 113 (2006) 1575-1592
47. Verbaten M.N., Overtoom C.C., Koelega H.S., Swaab-Barneveld H., van der Gaag R.J., Buitelaar J., and van Engeland H. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. J. Abnorm. Child Psychol. 22 (1994) 561-578
48. Volkow N.D., Wang G.J., Fowler J.S., Telang F., Maynard L., Logan J., Gatley S.J., Pappas N., Wong C., Vaska P., Zhu W., and Swanson J.M. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am. J. Psychiatry 161 (2004) 1173-1180
49. Ward M.F., Wender P.H., and Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am. J. Psychiatry 150 (1993) 885-890
50. Wilens T.E., Biederman J., and Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am. J. Addict. 7 (1998) 156-163